comparemela.com

Latest Breaking News On - The united kingdom - Page 1 : comparemela.com

Sanlorenzo CEO Massimo Perotti's Innovative, Strategic, Italian Style

Massimo Perotti, Chairman and CEO of Sanlorenzo Group, engages his audience with passion.

La-spezia
Liguria
Italy
United-kingdom
France
United-states
London
City-of
America
British
American
Italian

SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report

United-kingdom
United-states
Germany
Japan
Dublin
Ireland
Italy
France
Spain
Clinical-development
Market-insight

REGN4461 (Mibavademab) for Lipodystrophy in 7MM: Market Size, Sales, Forecasts, and Emerging Insights 2019-2023, 2024-2032

Dublin, April 30, 2024 (GLOBE NEWSWIRE) The "REGN4461 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about REGN4461 for lipodystrophy in the seven major markets. A detailed picture of the REGN4461 for lipodystrophy in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report along

Germany
Japan
United-kingdom
United-states
France
Spain
Italy
Dublin
Ireland
Clinical-development
Emerging-insight

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.